Aralar inhibitors constitute a class of chemical compounds that are specifically designed to target and modulate the activity of the mitochondrial aspartate-glutamate carrier protein, commonly known as aralar. Aralar is a vital component of the malate-aspartate shuttle, a crucial system involved in transferring reducing equivalents across the inner mitochondrial membrane, which is essential for maintaining cellular energy balance and supporting various metabolic processes. The inhibition of aralar's function by these compounds impacts its ability to facilitate the transport of aspartate and glutamate, leading to perturbations in cellular metabolism. These inhibitors typically exert their effects by directly interacting with aralar's active site or binding domains, disrupting its conformational dynamics and substrate recognition. By doing so, they interfere with the transport of aspartate and glutamate between the cytoplasm and mitochondria, impairing the malate-aspartate shuttle's overall efficiency.
This disruption in substrate transport has cascading effects on cellular processes that rely on these amino acids, such as protein synthesis, energy production, and neurotransmitter metabolism. The mechanism of inhibition may involve competitive binding, where inhibitors vie for the active site, or allosteric interactions that induce structural changes in aralar's protein structure, preventing the proper coordination of substrates. In some cases, these inhibitors could also chemically modify aralar's active residues or functional groups, resulting in loss of transport activity. Aralar inhibitors find value as tools in probing the intricate role of aralar in cellular metabolism, shedding light on the pathways influenced by the malate-aspartate shuttle. Their specificity for aralar underscores the sophisticated regulation of mitochondrial transport systems and their broader impact on cellular physiology. By elucidating the molecular mechanisms underlying aralar inhibition, researchers gain insights into the intricate interplay between mitochondrial function, amino acid transport, and cellular energy dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
3-(3-Nitrophenyl)-2-propenoic Acid 2-[Methyl(tetrahydro-1,1-dioxido-3-thienyl)amino]-2-oxoethyl Ester | 749872-43-3 | sc-478170 | 10 mg | $380.00 | ||
This inhibitor is thought to modulate aralar's activity by interfering with its substrate binding or altering its conformation, resulting in reduced transport activity. | ||||||
L-Glutamic acid γ-(p-nitroanilide) hydrochloride | 67953-08-6 | sc-211703 sc-211703A sc-211703B sc-211703C | 500 mg 1 g 5 g 25 g | $72.00 $134.00 $458.00 $1572.00 | 4 | |
GPNA is believed to inhibit aralar's transport function by competitively binding to its substrate-binding site, thus preventing the binding and transport of substrates. | ||||||
β-Chloro-L-alanine | 2731-73-9 | sc-291972 sc-291972A | 1 g 5 g | $138.00 $581.00 | 1 | |
The inhibition by β-Chloro-L-alanine could involve structural modifications in aralar that impede substrate recognition and disrupt the transport process. | ||||||
L-Carnitine | 541-15-1 | sc-205727 sc-205727A sc-205727B sc-205727C | 1 g 5 g 100 g 250 g | $23.00 $34.00 $79.00 $179.00 | 3 | |
Carnitine might inhibit aralar by interfering with its substrate transport function, possibly by competing for binding to the transporter or disrupting its conformation. | ||||||